OSA phenotyping: is there value in guiding future therapies?
This keynote presentation by David White from Sleep DownUnder 2018 looks at OSA phenotyping and its potential value in developing future therapies.
Chairperson: Brad Edwards
ASA Member – Free
Non-Member - 40.00AUD
To view the full session recording, click Add to Cart below, then check out your cart to finalise your order. You will need to be logged in with your member details, or create an account on this website, to complete your order.